Sort
17,828 grants matching “crispr”
Defining mechanisms of disease and repair in a viral model of multiple sclerosis
$874,084Thomas E Lane · University Of California-Irvine · R35 · FY2023 · NS
Functional convergence following disruption of diverse genes associated with neurodevelopmental disorders
$873,525Kristen Jennifer Brennand · Yale University · R01 · FY2021 · MH
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells
$873,370Carol Prives · Columbia Univ New York Morningside · R35 · FY2018 · CA
Genomic characterization and development of therapies for pediatric sarcoma
$872,696John Shern · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Activation of Neuronal Degradative Pathways to Ameliorate Prion Disease
$871,963Sandra E Encalada · Scripps Research Institute, The · R56 · FY2023 · NS
Studying factors controlling cancer progression and immune recognition in mouse models
$871,800Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2022 · CA
ePACE: automation platforms for adaptable and scalable continuous evolution of biomolecules with therapeutic potential
$871,502Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2023 · EB
Non-coding genetic variants that impact immune phenotypes and diseases
$871,466Nir Hacohen · Broad Institute, Inc. · R01 · FY2016 · HG
Mechanisms of Cell-Based Heart Regeneration
$871,202Charles E Murry · University Of Washington · R01 · FY2021 · HL
Mechanisms of Cell-Based Heart Regeneration
$871,202Nathan John Sniadecki · University Of Washington · R01 · FY2022 · HL
Mechanisms of Cell-Based Heart Regeneration
$871,202Charles E Murry · University Of Washington · R01 · FY2020 · HL
Defining mechanisms of disease and repair in a viral model of multiple sclerosis
$871,109Thomas E Lane · University Of California-Irvine · R35 · FY2025 · NS
Enhanced radiotherapy for pediatric glioma via synthetic lethal vulnerabilities
$870,926Dipanjan Chowdhury · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Mechanisms of Cell-Based Heart Regeneration
$870,813Charles E Murry · University Of Washington · R01 · FY2019 · HL
Non-coding genetic variants that impact immune phenotypes and diseases
$870,754Nir Hacohen · Broad Institute, Inc. · R01 · FY2015 · HG
Non-coding genetic variants that impact immune phenotypes and diseases
$870,349Nir Hacohen · Broad Institute, Inc. · R01 · FY2017 · HG
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells
$870,147Carol Prives · Columbia Univ New York Morningside · R35 · FY2021 · CA
Optimization of CRISPR genome editor and its delivery strategy for C9orf72 frontotemporal dementia
$869,959Claire Clelland · University Of California, San Francisco · U01 · FY2023 · NS
Optimization of an in vivo base editing strategy to treat SOD1-linked ALS
$869,855Thomas Gaj · University Of Illinois At Urbana-Champaign · U01 · FY2022 · NS
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$868,716Nitin S Baliga · Institute For Systems Biology · R01 · FY2024 · AI
Mechanistic Investigation of RNA-Mediated Gene Regulation and Immunity
$868,299Ailong Ke · Cornell University · R35 · FY2021 · GM
Group II Intron and Related Reverse Transcriptases
$868,273Alan M. Lambowitz · University Of Texas At Austin · R35 · FY2022 · GM
Group II Intron and Related Reverse Transcriptases
$868,273Alan M. Lambowitz · University Of Texas At Austin · R35 · FY2021 · GM
Group II Intron and Related Reverse Transcriptases
$868,273Alan M. Lambowitz · University Of Texas At Austin · R35 · FY2024 · GM
Group II Intron and Related Reverse Transcriptases
$868,273Alan M. Lambowitz · University Of Texas At Austin · R35 · FY2023 · GM